The U.S. FDA granted Abbvie Inc. accelerated approval for antibody-drug conjugate (ADC) Teliso-V (telisotuzumab vedotin), newly branded Emrelis, making it the first treatment for previously treated ...

The interaction between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) has emerged as a key area of interest in ...

Despite that, the first RNA-targeting therapeutic in the market was launched only five years ago, and the vast majority of ...

In this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and ...

This valuable study provides insights into a key question in comparative neuroanatomy and development. The authors provide evidence of the role for a particular micro-RNA in regulating the development ...

Department of Physics, Florida International University, Miami, Florida 33199, United States Biomolecular Sciences Institute, Florida International University, Miami, Florida 33199, United States ...

Guangdong Provincial Key Laboratory of Sensing Technology and Biomedical Instrument, School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, Sun Yat-Sen University, Shenzhen ...

Ph.D., they show that one RNA-binding protein on the cell surface, NPM1, could be a potent, selective target for treating acute myeloid leukemia (AML), as well as solid tumors. AML, a rapidly ...

they show that one RNA-binding protein on the cell surface, NPM1, could be a potent, selective target for treating acute myeloid leukemia (AML), as well as solid tumors. AML, a rapidly progressive ...

Xiang-Qun Hu https://orcid.org/0000-0003-1626-9541 Lawrence D. Longo, MD Center for Perinatal Biology, Department of Basic Sciences, Loma Linda University School of ...